top of page
News, Events and Updates
Search
Mar 1, 2011
Anavex Appoints Dr. Jeffrey Cummings to its Scientific Advisory Board
Feb 24, 2011
Anavex Appoints Independent Director
Feb 23, 2011
Anavex Appoints Dr. Rachelle Doody to Scientific Advisory Board
Feb 16, 2011
Anavex Adds Dr. Paul Aisen to Scientific Advisory Board
Jan 18, 2011
Anavex Comments on President Obama’s Signing of National Alzheimer’s Project Act into Law
Jan 6, 2011
Alzheimer’s Weekly Names ANAVEX 2-73 the Number One Most Promising Trial Drug in Alzheimer’s Disease
Dec 21, 2010
Anavex Files Phase I Regulatory Submission for ANAVEX 2-73 in Alzheimer’s Disease
Sep 29, 2010
Anavex Appoints David Tousley as CFO
Sep 12, 2010
ANAVEX 2-73: Journal of Psychopharmacology Publishes Anti-Amnesic and Neuroprotective Data
Sep 10, 2010
Neuroprotective efficacy of ANAVEX 2-73, a novel tetrahydrofuran derivative targeting the sigma-1...
Sep 8, 2010
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/σ1 ligand ANAVEX 2-73
44
45
46
47
48
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
